Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rallybio (RLYB) Total Current Liabilities (2023 - 2025)

Historic Total Current Liabilities for Rallybio (RLYB) over the last 3 years, with Q3 2025 value amounting to $4.5 million.

  • Rallybio's Total Current Liabilities fell 4481.62% to $4.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.5 million, marking a year-over-year decrease of 4481.62%. This contributed to the annual value of $6.2 million for FY2024, which is 3261.36% down from last year.
  • Latest data reveals that Rallybio reported Total Current Liabilities of $4.5 million as of Q3 2025, which was down 4481.62% from $5.0 million recorded in Q2 2025.
  • Over the past 5 years, Rallybio's Total Current Liabilities peaked at $12.2 million during Q2 2024, and registered a low of $3.9 million during Q1 2025.
  • In the last 3 years, Rallybio's Total Current Liabilities had a median value of $8.1 million in 2023 and averaged $7.6 million.
  • Its Total Current Liabilities has fluctuated over the past 5 years, first surged by 5101.2% in 2024, then plummeted by 6123.34% in 2025.
  • Quarter analysis of 3 years shows Rallybio's Total Current Liabilities stood at $9.3 million in 2023, then crashed by 32.61% to $6.2 million in 2024, then fell by 27.6% to $4.5 million in 2025.
  • Its Total Current Liabilities was $4.5 million in Q3 2025, compared to $5.0 million in Q2 2025 and $3.9 million in Q1 2025.